Franklin Baker Company of the Philippines
FDA import alert and refusal historyLaguna, PhilippinesFEI 3004336886
As of October 27, 2026, Franklin Baker Company of the Philippines has no FDA import alert listing or import refusal in SupplierRadar's records; its most recent FDA inspection, on January 25, 2023, was classified NAI (No Action Indicated).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- Classified NAI (No Action Indicated)
Every FDA record for Franklin Baker Company of the Philippines
2 records, newest first. Each line links to the FDA page it came from.
Questions about Franklin Baker Company of the Philippines
- Is Franklin Baker Company of the Philippines on an FDA import alert?
- No listing for Franklin Baker Company of the Philippines appears in the FDA import alerts SupplierRadar checked on October 27, 2026. Country-wide alerts may still apply to its products; see the Philippines page.
- Has FDA refused shipments from Franklin Baker Company of the Philippines?
- No FDA import refusals for Franklin Baker Company of the Philippines appear in FDA's refusal data since October 2016, as of October 27, 2026.
- When was Franklin Baker Company of the Philippines last inspected by FDA?
- FDA's most recent inspection of Franklin Baker Company of the Philippines with a final classification is dated January 25, 2023 and was classified NAI (No Action Indicated).
- What is Franklin Baker Company of the Philippines's FEI number?
- Franklin Baker Company of the Philippines's FDA Establishment Identifier (FEI) is 3004336886.
Buying from Franklin Baker Company of the Philippines?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.